Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
A lot of making goes on in this community these days, but sometimes you’ve just gotta do some old fashioned hacking. You might have grabbed an old Speak and Spell that you want to repurpose ...
Mostly cloudy Monday with a few morning showers Windy and warmer Tuesday, a few showers Storms more likely starting Wednesday Storm chances continue into the weekend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results